Blake D, Gazzara M, Breuer I, Ferretti M, Lynch K
Sci Rep. 2024; 14(1):10987.
PMID: 38745101
PMC: 11094061.
DOI: 10.1038/s41598-024-61951-1.
Devarajan P, Vong A, Castonguay C, Silverstein N, Kugler-Umana O, Bautista B
Cell Rep. 2023; 42(10):113182.
PMID: 37776519
PMC: 10842051.
DOI: 10.1016/j.celrep.2023.113182.
Braun C, Azzano P, Gingras-Lessard F, Roy E, Samaan K, Graham F
Front Med (Lausanne). 2023; 10:1198173.
PMID: 37448803
PMC: 10336224.
DOI: 10.3389/fmed.2023.1198173.
Manjili M
J Immunol. 2023; 210(5):521-530.
PMID: 36881868
PMC: 10000300.
DOI: 10.4049/jimmunol.2200672.
Orlik C, Berschneider K, Jahraus B, Niesler B, Balta E, Schakel K
Front Immunol. 2022; 13:1016112.
PMID: 36353616
PMC: 9639098.
DOI: 10.3389/fimmu.2022.1016112.
Alternative splicing of apoptosis genes promotes human T cell survival.
Blake D, Radens C, Ferretti M, Gazzara M, Lynch K
Elife. 2022; 11.
PMID: 36264057
PMC: 9625086.
DOI: 10.7554/eLife.80953.
The adaptation model of immunity: Is the goal of central tolerance to eliminate defective T cells or self-reactive T cells?.
Manjili M
Scand J Immunol. 2022; 96(4):e13209.
PMID: 36239215
PMC: 9539632.
DOI: 10.1111/sji.13209.
Anti-Apoptotic c-FLIP Reduces the Anti-Tumour Activity of Chimeric Antigen Receptor T Cells.
Tan G, Poudel A, Ali Hosseini Rad S, McLellan A
Cancers (Basel). 2022; 14(19).
PMID: 36230780
PMC: 9564159.
DOI: 10.3390/cancers14194854.
The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function.
Blake D, Lynch K
Immunol Rev. 2021; 304(1):30-50.
PMID: 34368964
PMC: 8616797.
DOI: 10.1111/imr.13018.
Development of CAR-T Cell Persistence in Adoptive Immunotherapy of Solid Tumors.
Fan J, Das J, Xiong X, Chen H, Song J
Front Oncol. 2021; 10:574860.
PMID: 33489881
PMC: 7815927.
DOI: 10.3389/fonc.2020.574860.
Promoter choice: Who should drive the CAR in T cells?.
Rad S M A, Poudel A, Tan G, McLellan A
PLoS One. 2020; 15(7):e0232915.
PMID: 32706785
PMC: 7380635.
DOI: 10.1371/journal.pone.0232915.
Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.
Shamriz O, Simon A, Lev A, Megged O, Ledder O, Picard E
Clin Exp Immunol. 2020; 200(3):215-227.
PMID: 32201938
PMC: 7232008.
DOI: 10.1111/cei.13432.
Keratinocytes costimulate naive human T cells via CD2: a potential target to prevent the development of proinflammatory Th1 cells in the skin.
Orlik C, Deibel D, Kublbeck J, Balta E, Ganskih S, Habicht J
Cell Mol Immunol. 2019; 17(4):380-394.
PMID: 31324882
PMC: 7109061.
DOI: 10.1038/s41423-019-0261-x.
Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage .
Issa F, Milward K, Goto R, Betts G, Wood K, Hester J
Front Immunol. 2019; 10:889.
PMID: 31068951
PMC: 6491764.
DOI: 10.3389/fimmu.2019.00889.
T Cell Dysfunction in Cancer.
Thommen D, Schumacher T
Cancer Cell. 2018; 33(4):547-562.
PMID: 29634943
PMC: 7116508.
DOI: 10.1016/j.ccell.2018.03.012.
T-cell regulation through a basic suppressive mechanism targeting low-density lipoprotein receptor-related protein 1.
Panezai J, Bergdahl E, Sundqvist K
Immunology. 2017; 152(2):308-327.
PMID: 28580688
PMC: 5588768.
DOI: 10.1111/imm.12770.
CD28 Costimulation: From Mechanism to Therapy.
Esensten J, Helou Y, Chopra G, Weiss A, Bluestone J
Immunity. 2016; 44(5):973-88.
PMID: 27192564
PMC: 4932896.
DOI: 10.1016/j.immuni.2016.04.020.
Impaired T-cell differentiation in diabetic foot ulceration.
Moura J, Rodrigues J, Goncalves M, Amaral C, Lima M, Carvalho E
Cell Mol Immunol. 2016; 14(9):758-769.
PMID: 26996067
PMC: 5596240.
DOI: 10.1038/cmi.2015.116.
Temporal protein expression pattern in intracellular signalling cascade during T-cell activation: a computational study.
Ganguli P, Chowdhury S, Bhowmick R, Sarkar R
J Biosci. 2015; 40(4):769-89.
PMID: 26564978
DOI: 10.1007/s12038-015-9561-1.
Natural Killer Cell Functional Activity After 4-1BB Costimulation.
Navabi S, Doroudchi M, Tashnizi A, Habibagahi M
Inflammation. 2014; 38(3):1181-90.
PMID: 25520217
DOI: 10.1007/s10753-014-0082-0.
